awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38728508-9E9BDC00-5BC5-4734-8010-8DA9C921D36D
Q38728508-9E9BDC00-5BC5-4734-8010-8DA9C921D36D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38728508-9E9BDC00-5BC5-4734-8010-8DA9C921D36D
Investigational ErbB-2 tyrosine kinase inhibitors for the treatment of breast cancer.
P2860
Q38728508-9E9BDC00-5BC5-4734-8010-8DA9C921D36D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38728508-9E9BDC00-5BC5-4734-8010-8DA9C921D36D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
357017355d1b4ee4eeff726962a2634256eeb694
P2860
A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancer